TRUADVICE’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
TRUADVICE's LLY Position: Q3 2023 in Review
TRUADVICE reduced its Eli Lilly (LLY) stake by 9.6% in Q3 2023, selling an estimated $100K and leaving 1,835 shares worth $1.1M. The position accounts for 0.43% of the portfolio, ranked #65.
TRUADVICE first reported a position in LLY in Q2 2022 and has held it in 6 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- TRUADVICE held 1,835 shares of Eli Lilly worth $1.1M as of Q3 2023.
- TRUADVICE sold 195 Eli Lilly shares in Q3 2023, an estimated $100K.
- Eli Lilly made up 0.43% of TRUADVICE's portfolio in Q3 2023, its #65 holding.
- TRUADVICE first reported a position in Eli Lilly in Q2 2022 and has held it in 6 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.